These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11220551)

  • 21. Thiazolidinediones exert different effects on insulin resistance between dexamethasone-treated rats and wistar fatty rats.
    Kimura M; Daimon M; Tominaga M; Manaka H; Sasaki H; Kato T
    Endocr J; 2000 Feb; 47(1):21-8. PubMed ID: 10811289
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.
    Bergeron R; Previs SF; Cline GW; Perret P; Russell RR; Young LH; Shulman GI
    Diabetes; 2001 May; 50(5):1076-82. PubMed ID: 11334411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic effects of troglitazone in the Goto-Kakizaki rat, a non-obese and normolipidemic rodent model of non-insulin-dependent diabetes mellitus.
    O'Rourke CM; Davis JA; Saltiel AR; Cornicelli JA
    Metabolism; 1997 Feb; 46(2):192-8. PubMed ID: 9030828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rosiglitazone improves muscle insulin sensitivity, irrespective of increased triglyceride content, in ob/ob mice.
    Muurling M; Mensink RP; Pijl H; Romijn JA; Havekes LM; Voshol PJ
    Metabolism; 2003 Aug; 52(8):1078-83. PubMed ID: 12898477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male wistar rats.
    Hevener AL; Reichart D; Janez A; Olefsky J
    Diabetes; 2001 Oct; 50(10):2316-22. PubMed ID: 11574414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of plasma insulin concentration in regulating glucose and lipid metabolism in lean and obese Zucker rats.
    Noshiro O; Hirayama R; Shimaya A; Yoneta T; Niigata K; Shikama H
    Int J Obes Relat Metab Disord; 1997 Feb; 21(2):115-21. PubMed ID: 9043965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Triglyceride-lowering effect of a novel insulin-sensitizing agent, JTT-501.
    Shibata T; Matsui K; Yonemori F; Wakitani K
    Eur J Pharmacol; 1999 May; 373(1):85-91. PubMed ID: 10408254
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
    Sugiyama Y; Taketomi S; Shimura Y; Ikeda H; Fujita T
    Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of intramyocellular lipid following short-term rosiglitazone treatment in Zucker fatty rats: an in vivo nuclear magnetic resonance study.
    Jucker BM; Schaeffer TR; Haimbach RE; Mayer ME; Ohlstein DH; Smith SA; Cobitz AR; Sarkar SK
    Metabolism; 2003 Feb; 52(2):218-25. PubMed ID: 12601636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of hepatic glucose production on acute insulin resistance induced by lipid-infusion in awake rats.
    Li L; Yang GY
    World J Gastroenterol; 2004 Nov; 10(21):3208-11. PubMed ID: 15457577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance.
    Zinker B; Mika A; Nguyen P; Wilcox D; Ohman L; von Geldern TW; Opgenorth T; Jacobson P
    Metabolism; 2007 Mar; 56(3):380-7. PubMed ID: 17292727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Beta-cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death.
    Finegood DT; McArthur MD; Kojwang D; Thomas MJ; Topp BG; Leonard T; Buckingham RE
    Diabetes; 2001 May; 50(5):1021-9. PubMed ID: 11334404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative.
    Shibata T; Matsui K; Nagao K; Shinkai H; Yonemori F; Wakitani K
    Eur J Pharmacol; 1999 Jan; 364(2-3):211-9. PubMed ID: 9932726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats.
    Murakami K; Tobe K; Ide T; Mochizuki T; Ohashi M; Akanuma Y; Yazaki Y; Kadowaki T
    Diabetes; 1998 Dec; 47(12):1841-7. PubMed ID: 9836514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the new oral antidiabetic agent (-)-BM 13.0913.Na on insulin resistance in lean and obese Zucker rats.
    Apweiler R; Kühnle HF; Ritter G; Schell R; Freund P
    Metabolism; 1995 May; 44(5):577-83. PubMed ID: 7752904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of troglitazone on plasma homocysteine, hepatic and red blood cell S-adenosyl methionine, and S-adenosyl homocysteine and enzymes in homocysteine metabolism in Zucker rats.
    Fonseca V; Keebler M; Dicker-Brown A; Desouza C; Poirier LA; Murthy SN; McNamara DB
    Metabolism; 2002 Jun; 51(6):783-6. PubMed ID: 12037736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of free fatty acid-induced insulin resistance on plasma ghrelin level: an experimental study with rats].
    Li L; Yang GY
    Zhonghua Yi Xue Za Zhi; 2004 Oct; 84(19):1645-8. PubMed ID: 15569462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat.
    Hallakou S; Doaré L; Foufelle F; Kergoat M; Guerre-Millo M; Berthault MF; Dugail I; Morin J; Auwerx J; Ferré P
    Diabetes; 1997 Sep; 46(9):1393-9. PubMed ID: 9287037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone.
    Miles PD; Romeo OM; Higo K; Cohen A; Rafaat K; Olefsky JM
    Diabetes; 1997 Nov; 46(11):1678-83. PubMed ID: 9356012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
    Frias JP; Yu JG; Kruszynska YT; Olefsky JM
    Diabetes Care; 2000 Jan; 23(1):64-9. PubMed ID: 10857970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.